Prevalence and Clinical Characteristics of Patients with Transthyretin Amyloidosis in the United States and Japan: Results from the OverTTuRe Study

被引：0

作者：

Wright, Jason ^{[1
]}

Alvarez, Christian S. ^{[2
]}

Hong, Lai San ^{[3
]}

Jarbrink, Krister ^{[4
]}

Kumar, Neela ^{[5
]}

Pao, Christina ^{[1
]}

Wittbrodt, Eric ^{[2
]}

Kohsaka, Shun ^{[6
]}

机构：

[1] AstraZeneca, BioPharmaceut Med, Global Med Affairs, Wilmington, DE USA

[2] AstraZeneca, BioPharmaceut Med, Cardiovasc Renal & Metab Epidemiol, Gaithersburg, MD USA

[3] Redsen Ltd, Bournemouth, Dorset, England

[4] AstraZeneca, Cardiovasc Renal & Metab Evidence, BioPharmaceut Med, Gothenburg, Sweden

[5] AstraZeneca, BioPharmaceut Med, Payer & Real World Evidence, Wilmington, DE USA

[6] Keio Univ, Sch Med, Dept Cardiol, Tokyo, Japan

来源：

METABOLISM-CLINICAL AND EXPERIMENTAL | 2024年 / 153卷

关键词：

Transthyretin amyloidosis; heart failure; hypertension; arrythmia; diabetes mellitus; renal failure; gastrointestinal dysfunction;

D O I：

10.1016/j.metabol.2024.155867

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

0061

引用

页数：1